25666543|t|Identification and management of alcohol withdrawal syndrome.
25666543|a|Symptoms of alcohol withdrawal syndrome (AWS) may develop within 6-24 h after the abrupt discontinuation or decrease of alcohol consumption. Symptoms can vary from autonomic hyperactivity and agitation to delirium tremens. The gold-standard treatment for AWS is with benzodiazepines (BZDs). Among the BZDs, different agents (i.e., long-acting or short-acting) and different regimens (front-loading, fixed-dose or symptom-triggered) may be chosen on the basis of patient characteristics. Severe withdrawal could require ICU admission and the use of barbiturates or propofol. Other drugs, such as alpha2-agonists (clonidine and dexmetedomidine) and beta-blockers can be used as adjunctive treatments to control neuroautonomic hyperactivity. Furthermore, neuroleptic agents can help control hallucinations. Finally, other medications for the treatment for AWS have been investigated with promising results. These include carbamazepine, valproate, sodium oxybate, baclofen, gabapentin and topiramate. The usefulness of these agents are discussed. 
25666543	33	60	alcohol withdrawal syndrome	Disease	MESH:D020270
25666543	74	101	alcohol withdrawal syndrome	Disease	MESH:D020270
25666543	103	106	AWS	Disease	MESH:D020270
25666543	182	189	alcohol	Chemical	MESH:D000438
25666543	226	249	autonomic hyperactivity	Disease	MESH:D000430
25666543	254	263	agitation	Disease	MESH:D011595
25666543	267	283	delirium tremens	Disease	MESH:D000430
25666543	317	320	AWS	Disease	MESH:D020270
25666543	329	344	benzodiazepines	Chemical	MESH:D001569
25666543	346	350	BZDs	Chemical	MESH:D001569
25666543	363	367	BZDs	Chemical	MESH:D001569
25666543	524	531	patient	Species	9606
25666543	610	622	barbiturates	Chemical	MESH:D001463
25666543	626	634	propofol	Chemical	MESH:D015742
25666543	674	683	clonidine	Chemical	MESH:D003000
25666543	688	703	dexmetedomidine	Chemical	-
25666543	771	799	neuroautonomic hyperactivity	Disease	MESH:D006948
25666543	850	864	hallucinations	Disease	MESH:D006212
25666543	915	918	AWS	Disease	MESH:D020270
25666543	980	993	carbamazepine	Chemical	MESH:D002220
25666543	995	1004	valproate	Chemical	MESH:D014635
25666543	1006	1020	sodium oxybate	Chemical	MESH:D012978
25666543	1022	1030	baclofen	Chemical	MESH:D001418
25666543	1032	1042	gabapentin	Chemical	MESH:D000077206
25666543	1047	1057	topiramate	Chemical	MESH:D000077236
25666543	Negative_Correlation	MESH:D000077236	MESH:D020270
25666543	Negative_Correlation	MESH:D000438	MESH:D020270
25666543	Negative_Correlation	MESH:D001569	MESH:D020270
25666543	Negative_Correlation	MESH:D000077206	MESH:D020270
25666543	Negative_Correlation	MESH:D015742	MESH:D020270
25666543	Negative_Correlation	MESH:D003000	MESH:D006948
25666543	Negative_Correlation	MESH:D012978	MESH:D020270
25666543	Negative_Correlation	MESH:D002220	MESH:D020270
25666543	Negative_Correlation	MESH:D001463	MESH:D020270
25666543	Negative_Correlation	MESH:D001418	MESH:D020270
25666543	Negative_Correlation	MESH:D014635	MESH:D020270

